42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-941352
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 15314333-5ad8-4917-9e26-0fd58985b6e1
[Document ID] => 941352
[Document naam] => 4.b.3._Additional safeguards securing the robustness & independence of the scientific review process for MAAs for COVID-19.docx.docx
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/document/VWS-WOO-08-941352
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-941352
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO
[DocumentPublicationDate] => 3 november 2020
[DocumentStatusCheckedDate] => 2026-04-28 21:13:11.196438
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 04:55:00
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 04:55:00
)
Document: VWS-WOO-08-941352
Klik om te vergroten
Document correcties
Geregistreerde datum: 20201103
Geregistreerde documentnaam: 4.b.3._Additional safeguards securing the robustness & independence of the scientific review process for MAAs for COVID-19.docx.docx
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| document_SectionDownloadButton | 1 | 2025-07-10 19:46:49 |
| DocumentDownload_linkname | Download (pdf, 2.06 MB) | 2025-07-10 19:46:49 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/file/download/document/1ee694b8-e85b-6582-b32c-2b7b8111b989 | 2025-07-10 19:46:49 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-941352.pdf | 2025-07-10 19:46:49 |
| document_documentName | 4.b.3._Additional safeguards securing the robustness & independence of the scientific review process for MAAs for COVID-19.docx.docx | 2025-06-22 23:39:41 |
| document_documentType | Word-document | 2025-06-22 23:39:41 |
| document_documentPublicationDate | 2020-11-03 | 2025-06-22 23:39:41 |
| document_documentNumber | VWS-WOO-08-941352 | 2025-06-22 23:39:41 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:39:41 |
| document_SectionHTMLDataDivs | 2 | 2025-06-22 23:39:41 |
| document_SectionAbout | 1 | 2025-06-22 23:39:41 |
| About_Datum document | 3 november 2020 | 2025-06-22 23:39:41 |
| About_Type bronbestand | Word-document, 3 pagina's | 2025-06-22 23:39:41 |
| About_Type bronbestand_paginas | 3 | 2025-06-22 23:39:41 |
| About_Download als | PDF (2.06 MB) | 2025-06-22 23:39:41 |
| About_Documentnummer | 941352 | 2025-06-22 23:39:41 |
| About_Beoordeling | Openbaarmaking | 2025-06-22 23:39:41 |
| About_Gelakte gegevens | Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:39:41 |
| About_Gelakte gegevens_linkhref_1 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over 4.b.3._Additional safeguards securing the robustness & independence of the scientific review process for MAAs for COVID-19.docx.docx (documentnummer 1ee694b8-e85b-6582-b32c-2b7b8111b989) | 2025-06-22 23:39:41 |
| About_Gelakte gegevens_linkname_1 | Laat het ons weten | 2025-06-22 23:39:41 |
| document_SectionRequest | 1 | 2025-06-22 23:39:41 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode november 2020 | 2025-06-22 23:39:41 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO | 2025-06-22 23:39:41 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode november 2020 | 2025-06-22 23:39:41 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 10 augustus 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode november 2020. | 2025-06-22 23:39:41 |
| Request_Periode | November 2020 | 2025-06-22 23:39:41 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:39:41 |
| Request_Datum besluit | 10 augustus 2022 | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking | 8.199 documenten, 34.478 pagina's Inventarislijst | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking_documenten | 8.199 | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking_paginas | 34.478 | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/file/download/inventory | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:39:41 |
Archiefversies (7 rijen)
Archiefrij 1 — 2025-09-07 17:32:48
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-941352.pdf
documentName: VWS-WOO-08-941352.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 2159089
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:32:48
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:32:48
lastSeen: 2025-09-07 17:32:48
text: EUROPEANMEDICINES AGENCY
MEDICINES HEALTH
25September 2020
EMA/MB/506190/2020
Management Board meeting of1October 2020
Additional safeguards tobeput inplace forsecuring the
robustness and independence ofthe scientific review
process forMarketing Authorisation Applications for
COVID-19 treatments-spe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 4c32c94521742cf6ec2b72ef77c396c61e1f093cf39aa157cd513c78917c0d9f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_77712_b619282a7f766bc2e2696977463803e8
textDigestSHA256: 8a2feea5bd64e313e061a596894165f8b6f19993aa0e31308db683e200cafdc8
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941352
Archiefrij 2 — 2025-09-04 16:59:32
fromFile: VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip
documentName: VWS-WOO-08-941352.pdf
documentType: pdf
documentCompressedSize: 1816473
documentSize: 2159089
documentCompressRatio: 84.13145544255008
documentDateModified: 2025-05-01 20:20:14
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:59:32
lastSeen: 2025-09-04 16:59:32
text: EUROPEANMEDICINES AGENCY
MEDICINES HEALTH
25September 2020
EMA/MB/506190/2020
Management Board meeting of1October 2020
Additional safeguards tobeput inplace forsecuring the
robustness and independence ofthe scientific review
process forMarketing Authorisation Applications for
COVID-19 treatments-spe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 4c32c94521742cf6ec2b72ef77c396c61e1f093cf39aa157cd513c78917c0d9f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip_403
textDigestSHA256: 8a2feea5bd64e313e061a596894165f8b6f19993aa0e31308db683e200cafdc8
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941352
Archiefrij 3 — 2025-09-04 16:37:56
fromFile: VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip
documentName: VWS-WOO-08-941352.pdf
documentType: pdf
documentCompressedSize: 1816473
documentSize: 2159089
documentCompressRatio: 84.13145544255008
documentDateModified: 2025-05-27 12:38:36
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:37:56
lastSeen: 2025-09-04 16:37:56
text: EUROPEANMEDICINES AGENCY
MEDICINES HEALTH
25September 2020
EMA/MB/506190/2020
Management Board meeting of1October 2020
Additional safeguards tobeput inplace forsecuring the
robustness and independence ofthe scientific review
process forMarketing Authorisation Applications for
COVID-19 treatments-spe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 4c32c94521742cf6ec2b72ef77c396c61e1f093cf39aa157cd513c78917c0d9f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip_385
textDigestSHA256: 8a2feea5bd64e313e061a596894165f8b6f19993aa0e31308db683e200cafdc8
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941352
Archiefrij 4 — 2025-03-18 09:30:25
fromFile: 2024.075-VWS-WOO-3405320-1033219-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3405320-1033219-PDO.zip
documentName: VWS-WOO-08-941352.pdf
documentType: pdf
documentCompressedSize: 1813155
documentSize: 2159089
documentCompressRatio: 83.97777951719452
documentDateModified: 2025-01-08 16:23:22
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:25
lastSeen: 2025-03-18 09:30:25
text: EUROPEANMEDICINES AGENCY
MEDICINES HEALTH
25September 2020
EMA/MB/506190/2020
Management Board meeting of1October 2020
Additional safeguards tobeput inplace forsecuring the
robustness and independence ofthe scientific review
process forMarketing Authorisation Applications for
COVID-19 treatments-spe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 8a2feea5bd64e313e061a596894165f8b6f19993aa0e31308db683e200cafdc8
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 324094
textDigestSHA256: 8a2feea5bd64e313e061a596894165f8b6f19993aa0e31308db683e200cafdc8
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941352
Archiefrij 5 — 2025-02-27 09:25:04
fromFile: 2023.057-VWS-WOO-3405320-1033219-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3405320-1033219-PDO.zip
documentName: VWS-WOO-08-941352.pdf
documentType: pdf
documentCompressedSize: 1813155
documentSize: 2159089
documentCompressRatio: 83.97777951719452
documentDateModified: 2025-01-08 16:23:22
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:04
lastSeen: 2025-02-27 09:25:04
text: EUROPEANMEDICINES AGENCY
MEDICINES HEALTH
25September 2020
EMA/MB/506190/2020
Management Board meeting of1October 2020
Additional safeguards tobeput inplace forsecuring the
robustness and independence ofthe scientific review
process forMarketing Authorisation Applications for
COVID-19 treatments-spe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 8a2feea5bd64e313e061a596894165f8b6f19993aa0e31308db683e200cafdc8
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 236648
textDigestSHA256: 8a2feea5bd64e313e061a596894165f8b6f19993aa0e31308db683e200cafdc8
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941352
Archiefrij 6 — 2025-02-18 12:18:13
fromFile: VWS-WOO-3405320-1033219-PDO-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3405320-1033219-PDO-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
documentName: VWS-WOO-08-941352.pdf
documentType: pdf
documentCompressedSize: 1813155
documentSize: 2159089
documentCompressRatio: 83.97777951719452
documentDateModified: 2025-01-08 16:23:22
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: EUROPEANMEDICINES AGENCY
MEDICINES HEALTH
25September 2020
EMA/MB/506190/2020
Management Board meeting of1October 2020
Additional safeguards tobeput inplace forsecuring the
robustness and independence ofthe scientific review
process forMarketing Authorisation Applications for
COVID-19 treatments-spe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 8a2feea5bd64e313e061a596894165f8b6f19993aa0e31308db683e200cafdc8
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 108183
textDigestSHA256: 8a2feea5bd64e313e061a596894165f8b6f19993aa0e31308db683e200cafdc8
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941352
Archiefrij 7 — 2025-02-18 12:18:03
fromFile: Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
documentName: VWS-WOO-08-941352-4.b.3._Additional_safeguards__securing_the_robustness___independence_of_the_scientific_review_process_for_MAAs_for_COVID-19.docx.docx.pdf
documentType: pdf
documentCompressedSize: 1813155
documentSize: 2159089
documentCompressRatio: 83.97777951719452
documentDateModified: 2024-08-27 10:34:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:03
lastSeen: 2025-02-18 12:18:03
text: leeg!
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: n/a
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 42536
textDigestSHA256: leeg!
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941352
(dit is ook een speeltuin)